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Outcomes in randomised controlled trials
in prevention and management of carious
lesions: a systematic review
Colin Levey1*, Nicola Innes1, Falk Schwendicke2, Thomas Lamont1 and Gerd Göstemeyer2
Abstract
Background: Inconsistent outcome reporting is one significant hurdle to combining results from trials into systematic
reviews. Core outcome sets (COS) can reduce this barrier. The aim of this review was to map outcomes reported in caries
prevention and management randomised controlled trials (RCT) as a first step to COS development. We also investigated
RCT characteristics and reporting of primary outcomes and sample size calculations.
Methods: PubMed, Embase, Web of Knowledge and Cochrane CENTRAL were systematically searched (1 January 1968 to
25 August 2015). Inclusion criteria: RCTs comparing any technique for prevention or management of caries with another
or placebo and RCTs comparing interventions to support patients undergoing treatment of caries (without setting,
dentition or age restrictions). Categories were developed through piloting and group consensus and outcomes grouped
accordingly.
Results: Of 4773 search results, 764 were potentially relevant, full text was available for 731 papers and 605 publications
met the inclusion criteria and were included. For all outcomes across the time periods 1968–1980 and 2001–2010,
reporting of outcome ‘caries experience’ reduced from 39% to 18%; ‘clinical performance of the restoration’ reporting
increased from 33% to 42% although there was a reduction to 22% in 2011–2015. Emerging outcome domains include
‘lesion activity’ and ‘pulp health-related outcomes’, accounting for 1% and 0%, respectively, during 1968–1980 and 10%
and 4% for 2011–2015. Reporting ‘resource efficiency’ and ‘quality of life measures’ have remained at a low level. No
publications reported tooth survival independent of an index such as DMFT or equivalent. Primary outcomes were only
identified as such in 414 (68%) of the reports.
Conclusions: Over the past 50 years, outcome reporting for trials on prevention and management of carious lesions
have tended to focus on outcomes measuring caries experience and restoration material clinical performance with
lesion activity and cost-effectiveness increasingly being reported. Patient-reported and patient-focused outcomes are
becoming more common (although as secondary outcomes) but remain low in use. The challenge with developing a
COS will be balancing commonly previously reported outcomes against those more relevant for the future.
Trial registration: PROSPERO, CRD42015025310. Registered on 14 August 2015, Trials (Schwendicke et al., Trials 16:397,
2015) and COMET initiative online (COMET, 2017).
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Background
Although preventable, dental caries continues to be one of
the most common diseases globally, carrying substantial
personal health impact and significant financial burden to
treat [1–4]. Imperfections in the conduct and reporting of
caries prevention and management trials has meant that
systematic reviews have only been able to present poor or
moderate quality evidence for even the most common
preventive and management interventions [5–13]. Inade-
quate participants recruited (sample sizes), clinical hete-
rogeneity, high risk of bias and inappropriate comparator
or outcome choice within caries prevention and manage-
ment trials have impacted negatively on the quality and
strength of evidence [14]. Trials are conducted which can
be combined together in systematic reviews to help create
guidelines. It is therefore critical that action is taken to im-
prove the quality of the evidence in the field of caries pre-
vention and management. Different research groups, like
Enhancing the QUAlity and Transparency of Health
Research (EQUATOR) and Core Outcome Measures in
Effectiveness Trials (COMET) have individually started to
improve the quality of evidence creation and synthesis
process. Overall, this approach follows a model of mar-
ginal gains [14].
One area where marginal gains can be made is in
the harmonisation of outcome reporting in clinical
trials. A trial outcome is the endpoint measured to
allow comparison between the control and the inter-
vention. It is what is measured (e.g. lesion activity),
rather than how it is measured (the outcome meas-
ure, e.g surface texture index). Ensuring the best out-
comes are chosen is central to the quality of the trial
and the usefulness of the trial results.
A core outcome set (COS) is an agreed minimum
group of outcomes which should be measured and re-
ported for all trials involving a particular condition in a
particular population. COS development began in med-
ical fields in the 1990s [15] to address the problem of
poor selection and reporting of trial outcomes. A Lancet
Series on improving trial quality and reducing research
waste [16–18] highlighted that ‘outcomes should be of
importance to patients and not merely those that will
show a statistically significant difference or are simplest
to measure’. As well as harmonising outcomes to enable
trial results synthesis in systematic reviews, a COS also
reduces selective outcome reporting. This occurs when
only statistically significant results are reported and sta-
tistically insignificant results are not. This can lead to a
body of literature which overestimates treatment effect
and under-reports harm [19–21]. This potentially skews
the evidence and could have a significant, and negative,
impact upon individual patients and healthcare systems,
through the provision of costly, ineffective and/or per-
haps harmful interventions.
In the dental literature, the importance of COS devel-
opment is of growing interest [14, 22–25]. The first stage
of COS development is to investigate outcomes that
have previously been, and are currently, in use [26].
Therefore, there is a need to examine outcomes within
the published literature around dental caries, look for
trends and consider future priorities [27].
Stating and defining the primary outcome of a trial is
a key recommendation of the CONSORT statement [28].
The primary outcome should be the outcome of greatest
therapeutic importance [29]. It is used to calculate the
number of participants required for the study to detect a
difference between interventions and should be clearly
identified a priori. Additional (secondary) outcomes may
also be measured within a trial but are not the primary
focus.
Prospective public trial registration is another recom-
mendation of the CONSORT statement [28]. Trial pro-
tocols should be registered before commencing a study
and can be used to confirm whether the study has been
conducted as planned. In the context of outcome selec-
tion, the primary outcome in the report should be the
one used in the registered protocol. This helps to iden-
tify outcome reporting bias.
The scope of this review is deliberately broad to cap-
ture a picture of outcomes to inform the COS develop-
ment process. The primary aim of this review was to
establish which outcomes have been used to assess treat-
ment effect in randomised controlled trials (RCTs) of in-
terventions for prevention or management of carious
lesions in adults or children.
The secondary aims were:
1. to describe the characteristics of included trials; and
2. to assess compliance with reporting key aspects of the
CONSORT statement related to handling of outcomes:
a. sample size calculations and their relationship with
the primary outcome; and
b. trial registration.
Methods
The protocol for this review was published in BMC Trials
[26] and registered in PROSPERO (CRD42015025310)
and on the COMET initiative website [30].
Searches
Two search strategies were developed: the first focused on
the prevention and the second on management of carious
lesions (Table 1). Searches were developed and run indi-
vidually for Embase, Web of Knowledge, PubMed and
CENTRAL in August 2015 without language restrictions.
Hand searching or assessment of the grey literature was
not conducted for this review because it was considered
unlikely to yield new outcome domains or significantly
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alter the overall results due to the high number of included
publications.
Inclusion criteria
We included RCTs involving any technique for pre-
venting or managing carious lesions when compared
to another intervention or no treatment. To capture
patient-centred outcomes, we also included studies
comparing interventions to support patients undergo-
ing procedures related to caries. There were no re-
strictions on setting, time of follow-up, age or
whether the study investigated the primary or per-
manent dentition. Artificial lesions and in situ studies
were excluded. Screening of titles and abstracts was
carried out independently and in duplicate by four
authors (CL, FS, GG and NI) with agreement of two
authors required for inclusion. Following screening
for eligibility, 13 full text articles were not in English
or German (languages spoken by the authors). As
these made up only 1.7% of the total number of po-
tentially eligible studies, they were excluded without
translation.
Data extraction
Data were extracted singly and independently by five
authors (CL, FS, GG, NI and TL) following calibra-
tion using a pilot database. Independent extraction
was chosen because numerical data were not being
extracted and the risk of errors or missing outcomes
was considered to be of low risk to data integrity. A
5% data check was undertaken and fields showing
non-conformity > 10% were re-extracted after a further
round of calibration. Due to the large number of in-
cluded articles and the aim of our review, each article
was included as a separate entity.
Data extracted:
 Trial details (author name, title, journal, date of
publication);
 Trial characteristics;
 ○ Study setting
 ○ Number/age of participants
 ○ Dentition
 ○ Number of trial arms
 ○ Interventions compared
 ○ Prevention or management
 Outcomes assessed (collected as either stated primary
outcome(s) or secondary outcome(s));
 Sample size calculation and whether it related to the
primary outcome; and
 Trial registration.
Studies with interventions to avoid new lesions were
assigned to prevention, while studies with interventions
targeting existing lesions were assigned to management.
An outcome was considered a primary outcome if it was
stated as such or where the report clearly focused on
one outcome. If no primary outcome was identifiable or
multiple outcomes were reported these were considered
secondary outcomes.
Strategy for data synthesis
A list of outcomes was compiled and those with differ-
ent verbatim terms but similar meanings were gathered
using a single agreed term. Pilot category names were
agreed before a first round of categorisation and refined
through group consensus before all outcomes were re-
categorised using the final agreed terms. The final list of
outcome categories comprised 19 items and one ‘other’
category: caries experience (including DMFT, etc.); clin-
ical performance of the restoration; lesion activity;
microbiological outcomes; clinical oral hygiene-related
outcomes (e.g. plaque and gingival indices); reaction to
treatment during treatment procedure; pulp health-
related outcomes; resource efficiency, e.g. time, cost; sys-
temic side effects; pain/ discomfort, distinct from, and at
a distance to, treatment; quality of life/subjective value;
patient behaviour outcomes, e.g. toothbrushing fre-
quency; patient knowledge; acceptability to operator;
fluoride side-effects; aesthetics; service use; clinical diet-
related, e.g. blood sugar levels; tooth survival; other.
Trial outcomes were allocated to one of these outcome
categories by discussion and agreement of two authors
(CL and NI). Where there was divergence, consensus
was achieved through discussion with all five authors. A
common area of difficulty was in deciding whether a
particular outcome should be assigned to the caries ex-
perience or lesion activity outcome category. In such sit-
uations, if the outcome was related to caries progression
Table 1 Medline search strategies
Prevention of carious lesions Medline search
Search (((((((((((((fluoride) OR sealant) OR sealing) OR remineralisation)
OR remineralization) OR remineralise) OR remineralize) OR antibacterial)
OR chlorhexidine) OR brushing) OR brush))) AND (((((((((((((progression)
OR prevention) OR arrest) OR prevent) OR progress) OR activity)))) AND
(decay) OR carious) OR dmft) OR dmfs)))) AND ((((((patients) OR clinical)
OR randomized) OR randomised) OR random)))))
Management of carious lesions Medline search
Search ((“Tooth”[Mesh]) AND “Dental Caries”[Mesh]) AND
((((((((((“pit and fissure sealant” OR “pit and fissure sealants”))) OR
(“Pit and Fissure Sealants”[Mesh])) OR “Dental Restoration,
Permanent”[Mesh]) OR “Dental Restoration, Temporary”[Mesh]) OR
(((ultraconservative[Title/Abstract] OR stepwise excavation*[Title/
Abstract] OR atraumatic*[Title/Abstract] OR minim*[Title/Abstract]))
OR (ultraconservative[Text Word] OR stepwise excavation*[Text
Word] OR atraumatic*[Text Word] OR minim*[Text Word]))) OR
“Dental Cements”[Mesh]) OR “Dental Amalgam”[Mesh]) OR “Resins,
Synthetic”[Mesh])
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within a single tooth or tooth level results, it was cate-
gorised as lesion activity. If it was reported at the patient
level using a caries experience index, it was categorised
as additional caries experience.
Results
Included studies
From the search, 5197 articles were identified across all
databases and 4773 after duplicates removed. These
were screened for eligibility independently and in dupli-
cate by four authors (CL, FS, GG and NI) with agree-
ment of two authors required for inclusion. There were
764 potentially relevant articles and the full texts of 731
were located (96% retrieval rate) with 126 of the re-
trieved articles excluded (not meeting inclusion criteria
or not available in English or German). This left 605 full
text articles in the final dataset for analysis (Fig. 1).
Characteristics of included trials
Study setting
Of the 605 included reports, it was not possible to deter-
mine the study setting for 131 (22%) reports. Of the
remaining 474, 73 (15%) were conducted in the primary
care setting, 195 (41%) in secondary care (specialist
practice, hospital or university), while 188 (40%) were
set in a non-practice setting (field or school) and 18
(4%) in a mixed setting.
Number of participants
The total number of participants in the included trial
reports was 252,099 (range = 7–8027 participants per
trial), median 102 participants, mean 429 (interquartile
range [IQR] = 284; qL44, qU328). Participant numbers
were not normally distributed across the trials (Fig. 2).
The total number of participants in prevention trial re-
ports was 208,817 (range = 10–8027 participants per
trial), median 257 participants, mean 735 (IQR = 512:
qL99, qU611). The total number of participants in
management trial reports was 43,282 (range = 7–8027
participants per trial), median 52 participants, mean
142 (IQR = 87: qL33, qU120).
Age of participants
Children (aged < 18 years) were the sole focus of 416 re-
ports (69%) and adults in 154 (25%). Both adults and
children were studied in 32 reports (5%). In three publi-
cations (0.5%) it was not possible to determine whether
the participants were adults, children or both.
Primary/permanent dentition
Although 448 (74%) of the articles involved children
(416 with children alone and 32 with both children
and adults), the permanent dentition was studied in
447 (74%) of the trial reports (349 [58%] involving
the permanent dentition alone and 98 [16%] for both
the primary and permanent dentitions). The primary
dentition was the focus in 150 (25%) of the studies.
Fig. 1 PRISMA flow diagram of search strategy and numbers of studies found, included and excluded (with reasons)
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In eight (1%) of the reports, it was unclear which dentition
was being studied.
Number of arms per trial
There were 415 (69%) reports describing trials with
two arms; 124 trials (21%) had three arms, 44 (7%)
had four arms and 22 (4%) of the reports had five or
more trial arms.
More detail on the report characteristics of the in-
cluded studies can be found in Additional file 1.
Outcomes
All outcomes
There were 1363 outcomes reported in 605 published re-
ports (Fig. 3). ‘Clinical performance of the restoration’ and
‘caries experience (e.g. DMFT)’ were the most common
outcomes reported: 481 (35%) and 344 (25%) respectively.
The next most common were ‘microbiological outcomes’
103 (8%), ‘clinical oral-hygiene-related outcomes’ 87 (6%),
‘lesion activity’ 76 (6%) and ‘patient reaction to treatment
during treatment procedure’ 66 (5%). There was around a
10% reduction each in the proportion of reports assessing
‘caries experience’ and ‘clinical performance of the restor-
ation (from 1968–1980 to 2011–2015). At the height of
their use (1981–1990), these outcome domains combined
accounted for 79% of all reported outcomes, while most
recently (2011–2015), this had fallen to 51%. Outcome
domains that have increased in use include ‘lesion ac-
tivity’, ‘microbiological outcomes’, participants’ ‘reaction
to treatment during procedure’, ‘pulp health-related out-
comes’ and ‘resource efficiency’.
Primary outcomes
Primary outcomes could be identified in 414 (68%) reports
(Fig. 4). Between 1968 and 2015, ‘clinical performance of
the restoration’ was measured in 151 (35%) of these re-
ports and ‘caries experience’ in 155 (36%), accounting for
over two-thirds of the studies’ main focus. ‘Lesion activity’
was not measured in any studies in 1968–1980 rising from
3% (1981–1990), 4% (1991–2000), 6% (2001–2010) to 16%
(2011–2015). Similar, although smaller increases are seen
in ‘microbiological outcomes’, participants’ ‘reaction to
treatment during treatment procedure’ and ‘pulp-health-
related outcomes’, showing them also to be of growing
interest as primary outcomes and the focus of the study.
Sample size calculations and primary outcomes
Information on sample size calculation was provided in
104 reports with the proportion increasing over time
(Fig. 5). Fifty-five (44%) of all published reports in the
2011–2015 time period reported a sample size calcula-
tion. Overall (1968–2015) the sample size calculation
was only linked to the primary outcome in 12% of all in-
cluded reports.
Of the 104 reports which had a sample size calcula-
tion, 75 (72%) related to the primary outcome. The sam-
ple size calculation did not clearly relate to the primary
Fig. 2 Logarithmic scale frequency distribution of the number of participants per trial (n = 252,099), by trial type. Participants in trials of caries
management n = 43,282 (range = 7–8027) and for caries prevention trials n = 208,817 (range = 10–8027)
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outcome in 6% of publications and the information was
unclear in 22% of reports.
Trial registration reporting
Only 37 (6%) of all articles reported a trial registration in
line with the CONSORT statement [28]. In the ten years
following the publication of the first CONSORT statement
in 2001, 3% of reports included a trial registration. Follo-
wing the publication of the second CONSORT statement
in 2010, this had risen to 21% (time period 2011–2015).
Discussion
This systematic review of caries prevention and mana-
gement trials’ outcomes gives a picture of RCTs over
Fig. 3 All reported outcomes (primary and secondary) for RCTs of carious lesion prevention and management (1968–2015), presented by domain
and timeframes (n = 1364 outcomes)
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time. The outcomes that have been investigated show
where emphasis has changed and which outcomes have
been, and are becoming, of interest. It has also enabled
identification of outcome domains for inclusion in a
subsequent consensus process to determine a caries
management COS.
The most commonly investigated outcome domains
were ‘clinical performance of the restoration’ (assessed
by the researcher or clinician) and ‘caries experience’
following an intervention. There was a paucity of trials
where the outcome domains were patient-focused.
Report characteristics
The vast majority of caries prevention and management
interventions are provided in the primary dental care en-
vironment. However, only 15% of the reports (where this
Fig. 4 Primary outcomes reported in RCTs of carious lesion prevention and management (1968–2015), presented by domain and timeframes
(n = 415 outcomes)
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information could be determined) were conducted in
this setting, with 41% set in secondary care. The repre-
sents an experimental focus on efficacy of interventions
rather than effectiveness, within dental and oral health-
care. Non-practice settings such as schools provide a
reliable participant group for caries prevention interven-
tions involving large numbers of participants, which may
explain why 40% of all reports were in this setting. This
could also explain why most studies are carried out on
only children and adolescents (69%) although the major-
ity (74%) investigated the permanent dentition. The gen-
eralisability of studies carried out on young people’s
permanent teeth (immature enamel, large pulp-to-crown
ratios) to the vast majority of users of dental care ser-
vices (adults) is questionable.
There was a wide range in the number of participants
in each trial. The median was 102 and the mean 429
(IQR = 284). There were a relatively small number of
studies with very large numbers of participants, skewing
the data from a normal distribution. In general, preven-
tion trials were larger than management trials with me-
dian participant numbers of 257 and 52, respectively.
This may be because much larger sample sizes are re-
quired to show differences in preventively based inter-
ventions. They also tended to be population-relevant
interventions such as school-based toothpaste/brushing
Fig. 5 Percentage of publications with a sample size calculation for RCTs of carious lesion prevention and management (1968–2015) (n = 606
trial reports)
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programmes. The total number of participants involved
in all of the trial reports was 252,099. This does not take
into account multiple counting of participants because
of trial reports being split across several publications
and so is likely to be an overestimate. Although it is not
possible to know how close this figure is to the actual
number of participants, it is the most accurate figure we
could achieve.
Trial outcomes
Selecting the most appropriate outcome category in
which to place each reported outcome presented a chal-
lenge which is consistent with other data in the oral
health field [23]. Often, this was because the outcomes
were poorly defined or were closely or inter-related [31].
Instances of overlap of outcome domains also resulted
from composite outcome measurement tools. Indeed,
this presents a potential challenge to COS development
for carious lesion management, as the measurement
tools for restoration performance (e.g. Ryge criteria) and
further caries experience (Decayed Missing or Filled
Teeth or Surfaces [DMFT or DMFS]) are frequently
used as stand-alone outcomes rather than as a tool to
measure a single clearly defined outcome. For example,
DMFT tends to be used to describe ongoing caries ex-
perience, i.e. disease activity at the patient level, rather
than simply tooth survival, although the latter is in-
cluded in the ‘M’ assessment. It is perhaps surprising
that tooth survival was not a standalone outcome in any
study; that is, apart from its inclusion within a compos-
ite measure, e.g. DMFT. In this review, DMFT and simi-
lar indices were assigned to the caries experience
category. Another common composite outcome meas-
ure, the Ryge criteria describes the clinical attributes and
performance of restorative materials. This tool includes:
a score for secondary caries development which could
also be categorised as ‘caries experience’ or ‘lesion activ-
ity’; and marginal discolouration, which is an aesthetic
outcome. We made consensus-led, clear decisions over
how to categorise these outcomes into domains, aiming
for clarity and consistency.
In some cases, the measurement tools appear to dictate
the outcome domain and the outcome is poorly, or never,
defined. A COS would harmonise the definition of out-
come domains so that these can be compared in a meta-
analysis. The COS development process should include
clear definitions of outcomes to ensure consistency in ap-
plication across future trials [32].
The outcomes reported in the caries literature from
1968 to 2015 have focussed on two areas; ‘clinical per-
formance of the restoration’ (assessed by the researcher
or clinician) and the amount of ‘caries experience’ fol-
lowing an intervention (often DMFT or similar). The
importance of restoration performance is probably re-
lated to the rapid development of dental materials start-
ing in the 1970s and continuing to the present day,
whereas interest in measurement of amount of caries is
likely to relates to fluoride toothpastes, gels and var-
nishes. Combined, these areas accounted for 74% of
primary outcomes and for 61% of all reported out-
comes. However, the use of these outcome domains ap-
pears to be reducing as a proportion of all reported
outcomes with pulpal health-related and economic out-
comes appearing to be of growing interest. These
changes may reflect the development of, and interest
in, minimally invasive approaches to lesion manage-
ment and interest in cost/benefit balance in resource-
limited healthcare settings.
Relatively few of the outcomes related to patient satis-
faction or quality of life (1%), anxiety or pain during
treatment (5%), discomfort after treatment (2%) or cost-
effectiveness/resource use (3%). This shows that out-
comes which are likely to be of importance to patients
are not prominent in investigations. Encouragingly,
patient-centred and patient-reported outcomes are in-
creasingly being investigated and reported. This disparity
strengthens the case for the development of a caries
management COS which embraces the patient voice, as
well as those from clinicians, researchers and other
stakeholders.
Our review highlights the complexities in handling
trial outcomes within the caries literature. For example,
about one-third (32%) of reports did not have a discer-
nible primary outcome so it was not possible to work
out what the authors intended the main comparison of
treatment success or failure to be. Even in the remaining
68%, the primary outcome was often not labelled as
such, but was the focus of the report. Since the term
‘primary outcome’ has only relatively recently been
adopted, we handled this by making a judgement on
what the intended primary outcome seemed to be in
these studies. This may not reflect an a priori primary
outcome, but rather may be a result of an emphasis be-
ing placed, by the authors, on a significant result from
an array of measured outcomes where the others were
less interesting or not significant. If there was ambiguity
over which outcome was the main outcome, all out-
comes were classified as secondary. Therefore, the com-
pliance with the CONSORT recommendations is likely
to be even poorer than these results suggest.
A priori trial registration, a recommendation of the
CONSORT statement [29, 33] would help with determining
the intended primary outcome(s), reducing selective out-
come reporting and improving standards within trials.
Overall, only 6% of studies reported a trial registration and
even taking a recent timeframe, between 2011 and 2015,
only 21% of publications referred to trial registration.
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Of 605 reports, only 104 gave a sample size calcula-
tion, and of these, only 75 related to the primary out-
come. This means that almost nine out of ten studies
(88%) did not report a sample size calculation at all or
reported one that was not based on the primary out-
come. Sample size calculations give a rational basis for
the number of participants needed in the study to detect
differences between the study interventions at an appro-
priate level of statistical confidence. They are a key rec-
ommendation in the CONSORT statement, published in
2001 [33] and revised in 2010 [29]. It is encouraging to
note that, since its revision, 33% of publications had a
sample size calculation which related to the primary out-
come which is a noticeable change since pre-CONSORT
statement levels (4%).
Strengths and limitations of review
There is ongoing work investigating the most efficient
systematic review methodology for outcome identifica-
tion prior to COS development and it has been sug-
gested that it may not be necessary to search multiple
databases and that outcome saturation can be achieved
by searching a subset of the literature [34]. However, in
this review, we did search multiple databases and ex-
tracted data from all included trials. We did not carry
out duplicate data extraction as the small gains in de-
tecting errors in outcomes being recoded were not com-
mensurate with the effort given our limited resources
[35]. However, to reduce the impact of this we under-
took a 5% data check.
It is standard practice for researchers to publish mul-
tiple reports based on data collected from the same clin-
ical trial [36]. This can be necessary to report on the
dataset at different timepoints but sometimes data col-
lected for different outcomes are split across multiple
publications. The complex task of linking registered
protocols to specific reports is difficult and relies on
aligning similar authorship and patient recruitment
numbers. However, this becomes even more difficult
when trials are not registered. We decided that while
it was preferable to focus on each trial as a whole, ra-
ther than reports, this could not be done within our
resources and was likely to have a limited impact on
the integrity of the data.
There is no accepted caries outcome classification sys-
tem and we derived the categories through an iterative
process involving piloting the system then refining it until
we agreed that the scheme was comprehensive but not
too detailed and we had gained consensus on category
names and allocation rules. Alternative classifications may
have resulted in changes to the granularity and focus of
the results. The broad scope of the categories may have
resulted in unique outcomes being subsumed into larger
categories. Any potential loss of information was mitigated
during the consensus process when all authors were in-
volved in suggesting novel outcome categories for
consideration.
Conclusions
Outcomes reported in RCTs for the prevention and man-
agement of carious lesions have tended to focus on the per-
formance of restorative materials (e.g. Ryge criteria) or
individual/population caries burden (e.g. DMFT or similar)
related to an intervention. Outcomes related to carious le-
sion activity, pulpal health and economics have grown in
use and are likely to be important in the future. Patient-
reported/patient-centred outcomes are rarely reported al-
though we found growing emphasis on outcomes of im-
portance to patients. This deficiency reinforces the need for
a COS with input from patients and other stakeholders
during its development. The challenge with developing a
caries lesion management COS will be balancing com-
monly reported outcomes (historic) against those more
relevant for the future of dental care of the patient with
dental caries.
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